Cargando…

Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib

Tumour necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) is a promising anti-cancer agent that rapidly induces apoptosis in cancer cells. Unfortunately, the clinical application of recombinant TRAIL (rTRAIL) has been hampered by its common cancer resistance. Naturally TRAIL is delivere...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Changhong, Hou, Huan, Li, Jiayu, Su, Kui, Huang, Chaohong, Lin, Yue, Lu, Zhiqiang, Du, Zhiyun, Tan, Wen, Yuan, Zhengqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281120/ https://www.ncbi.nlm.nih.gov/pubmed/32375399 http://dx.doi.org/10.3390/cancers12051157

Ejemplares similares

Pulmonary Delivery of Extracellular Vesicle-Encapsulated Dinaciclib as an Effective Lung Cancer Therapy
por: Yuan, Qian, et al.
Publicado: (2022)

Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
por: Shen, Xiao, et al.
Publicado: (2023)

TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2017)

Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
por: Buzzetti, Marta, et al.
Publicado: (2021)

Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
por: Chen, Zhenghu, et al.
Publicado: (2016)

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
por: Saqub, Hera, et al.
Publicado: (2020)

Study of the mechanism by which dinaciclib induces apoptosis and cell cycle arrest of lymphoma Raji cells through a CDK1‐involved pathway
por: Zhao, Huayan, et al.
Publicado: (2019)

Dinaciclib, a Bimodal Agent Effective against Endometrial Cancer
por: Howard, David, et al.
Publicado: (2021)

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
por: Gregory, G P, et al.
Publicado: (2015)

Neutrophil-derived trail is a proinflammatory subtype of neutrophil-derived extracellular vesicles
por: Youn, Young-Jin, et al.
Publicado: (2021)

A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
por: Lin, Shu-Fu, et al.
Publicado: (2017)

Dinaciclib as an effective pan-cyclin dependent kinase inhibitor in platinum resistant ovarian cancer
por: Howard, David, et al.
Publicado: (2022)

Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia
por: Pariury, Holly, et al.
Publicado: (2023)

Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment
por: Rimmer, Ella, et al.
Publicado: (2022)

MCL1 and BCL-xL Levels in Solid Tumors Are Predictive of Dinaciclib-Induced Apoptosis
por: Booher, Robert N., et al.
Publicado: (2014)

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer
por: Chen, Xiu-Xiu, et al.
Publicado: (2015)

Bcl-x(L) inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas
por: Rello-Varona, Santi, et al.
Publicado: (2019)

Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
por: Riess, Christin, et al.
Publicado: (2020)

A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer
por: Murphy, Adrian G., et al.
Publicado: (2020)

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
por: Gregory, Gareth P., et al.
Publicado: (2022)

Death Receptor 5 Displayed on Extracellular Vesicles Decreases TRAIL Sensitivity of Colon Cancer Cells
por: Setroikromo, Rita, et al.
Publicado: (2020)

Extracellular Vesicles: Delivery Vehicles of Myokines
por: Trovato, Eleonora, et al.
Publicado: (2019)

Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma
por: Hou, Chongchao, et al.
Publicado: (2022)

Clinical and laboratory studies of the novel cyclin-dependent kinase inhibitor dinaciclib (SCH 727965) in acute leukemias
por: Gojo, Ivana, et al.
Publicado: (2013)

The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
por: Desai, Brijal M., et al.
Publicado: (2013)

Extracellular vesicles: a rising star for therapeutics and drug delivery
por: Du, Shuang, et al.
Publicado: (2023)

Targeted delivery of extracellular vesicles in heart injury
por: Chen, Peier, et al.
Publicado: (2021)

Extracellular Vesicles as Drug Delivery Systems in Cancer
por: Hernandez-Oller, Laia, et al.
Publicado: (2020)

Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery
por: Ovchinnikova, Leyla A., et al.
Publicado: (2021)

Extracellular Vesicles for Drug Delivery in Cancer Treatment
por: Wang, Li, et al.
Publicado: (2023)

Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma
por: Qiu, Yongle, et al.
Publicado: (2020)

Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders
por: Pan, Renjie, et al.
Publicado: (2023)

TRAIL signals, extracellular matrix and vessel remodelling
por: Patil, Manisha S, et al.
Publicado: (2020)

Delivery of genome editing tools by bacterial extracellular vesicles
por: Liu, Yue, et al.
Publicado: (2018)

Drug Delivery with Extracellular Vesicles: From Imagination to Innovation
por: de Jong, Olivier G., et al.
Publicado: (2019)

Pathogenic Delivery: The Biological Roles of Cryptococcal Extracellular Vesicles
por: de Oliveira, Haroldo C., et al.
Publicado: (2020)

Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery
por: Dang, Xuan T. T., et al.
Publicado: (2020)

Extracellular Vesicles as Delivery Vehicles of Specific Cellular Cargo
por: Mir, Bilal, et al.
Publicado: (2020)

Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications
por: Wang, Liwei, et al.
Publicado: (2023)

Engineered Extracellular Vesicles for Drug Delivery in Therapy of Stroke
por: Ahmed, Waqas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5mbhhcr0n3o1579o37fqa8vp3c